Hydrotalcite

DB13322ApprovedInvestigationalWithdrawnSmall molecule

Hydrotalcite is an antacid indicated in the treatment of heartburn and excess gastric acid. A medication used to treat heartburn and other problems caused by stomach acid.

Mechanism: Pharmacologically active on Bile acids, Hydrogen ions, and Pepsin A-5
Curator reviewed
Formula / weight: CH₂₄Al₂Mg₆O₂₄ · 619.973 g/mol (avg)

Resolves to

Compound

UNII17432CG1KUCAS12304-65-3

Clinical / RWD

RxNorm27221ATCA02AD04

Structure

InChIKeyBEBILBPAQKONJS-UHFFFAOYSA-LSMILES

O.O.O.O.O.O.O.O.O.O.O.O.[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[Mg++].[Mg++].[Mg++].[Mg++].[Mg++].[Mg++].[Al+3].[Al+3].[O-]C([O-])=O

Targets

P0DJD9PGA5P0DJD7PGA4P0DJD8PGA3

What you can answer from here — as of July 07, 2026

5Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

414Drug interactionsStructured to mechanism, not free text

6Clinical trialsPhase, status and sponsor resolved per trial

1Structured indicationCondition, population, route and combination as fields, not prose

3ContraindicationsEach with its own population and attribute set

49Marketed productsAcross 6 countries and 16 labellers

1ATC codeIncluding every combination product, plus 15 drug categories

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Hydrotalcite, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account